Nanotechnology is a multidisciplinary science covering matters involving the nanoscale level that is being developed for a great variety of applications. Nanomedicine is one of these attractive and challenging uses focused on the employment of nanomaterials in medical applications such as drug delivery. However, handling these nanometric systems require defining specific parameters to establish the possible advantages and disadvantages in specific applications. This review presents the fundamental factors of nanoparticles and its microenvironment that must be considered to make an appropriate design for medical applications, mainly: (i) Interactions between nanoparticles and their biological environment, (ii) the interaction mechanisms, (iii) and the physicochemical properties of nanoparticles. On the other hand, the repercussions of the control, alter and modify these parameters in the biomedical applications. Additionally, we briefly report the implications of nanoparticles in nanomedicine and precision medicine, and provide perspectives in immunotherapy, which is opening novel applications as immune-oncology.
18 September 2006 in Journal of Pharmaceutical and Biomedical Analysis
This paper report a straightforward approach for the synthesis of CdSe quantum dots (CdSe QDs) in aqueous solution. This method, performed in homogeneous phase, affords optimal sizes and high quantum yields for each application desired. It is an a la carte procedure for the synthesis of nanoparticles aimed at their later application. By controlling the experimental conditions, CdSe QDs of sizes ranging between 2 and 6 nm can be obtained. The best results were achieved in an ice‐bath thermostated at 4°C, using mercaptoacetic acid as dispersant. Under these conditions, a slow growth of quantum nanocrystals was generated and this was controlled kinetically by the hydrolysis of to generate Se2−in situ, one of the forming species of the nanocrystal. The organic dispersant mercaptoacetate covalently binds to the Cd2+ ion, modifying the diffusion rate of the cation, and plays a key role in the stabilization of CdSe QDs. In optimum conditions, when kept in their own solution CdSe QDs remain dispersed over 4 months. The NPs obtained under optimal conditions show high fluorescence, which is a great advantage as regards their applications. The quantum efficiency is also high, owing to the formation under certain conditions of a nanoshell of Cd(OH)2, values of 60% being reached.
26 May 2009 in Journal of Environmental Monitoring
The bromate ion has been identified as an inorganic disinfection by-product (DPB) in water subjected to purification treatment. Its presence arises from the application of oxidation processes to water containing bromide through the action of oxidant agents such as the ozone used in ozonation processes. This ion has been identified as a possible carcinogen by the U.S. Environmental Protection Agency, which recommends a maximum concentration of 10 µgL−1. The literature reports a broad range of methods for the analysis of bromate in water, among which ion chromatography is the one most widely used, with different detection systems. However, most of the methods described to date require state-of-the-art technology and costly instrumentation, such that they are not readily adaptable to routine analyses. The present work reports a procedure for the spectrophotometric determination of bromate based on the bromination reaction of 3-3′ dimethoxybenzidine, o-dianisidine (ODA). The reaction is based on the formation of Br2 in the presence of excess bromide and the later bromination of ODA, generating a product that absorbs at 450 nm. The procedure was set up with Flow Injection Analysis and allows the determination of the analyte in the 8 µg L−1–3.3 mg L−1 range, with a detection limit of 6.0 µg L−1 and relative standard deviations (n = 12, [BrO3−] = 8.0 and 30.0 µg L−1) of 4.8% and 2.9%, respectively. The determination rate was 10–11 samples/hour.